Curanex regains Nasdaq $1 bid compliance
Curanex regained Nasdaq minimum bid-price compliance after a 1-for-20 reverse stock split completed on August 20, 2026.
Rhea-AI Filing Summary
Curanex Pharmaceuticals Inc (CURX) reports that it has regained compliance with Nasdaq’s minimum bid price requirement. The company had received a notice on November 5, 2025 that its stock traded below the required $1.00 closing bid price for 30 consecutive business days under Nasdaq Listing Rule 5550(a)(2).
On August 20, 2026, Curanex implemented a 1-for-20 reverse stock split of its outstanding common shares to address this issue. Nasdaq staff subsequently confirmed that from August 20, 2026 through September 2, 2026, the closing bid price was at or above $1.00 for 10 consecutive business days, so the company is now back in full compliance and the matter is considered closed.
Positive
- Regained Nasdaq compliance: After a 1-for-20 reverse stock split on August 20, 2026, Curanex’s stock closed at or above $1.00 for 10 consecutive business days, and Nasdaq confirmed the company is back in compliance with Listing Rule 5550(a)(2), closing the prior delisting matter.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Reverse stock split ratio: 1-for-20
Minimum bid price requirement: $1.00 per share
Bid-price compliance period: 10 consecutive business days
+2 more
5 metrics
Reverse stock split ratio
1-for-20
Reverse stock split of outstanding common stock effective August 20, 2026
Minimum bid price requirement
$1.00 per share
Nasdaq Listing Rule 5550(a)(2) minimum closing bid for continued listing
Bid-price compliance period
10 consecutive business days
Closing bid price at or above $1.00 from August 20, 2026 to September 2, 2026
Initial deficiency notice date
November 5, 2025
Date Nasdaq Listing Qualifications Department notified Curanex of bid-price deficiency
Compliance determination date
September 3, 2026
Date Nasdaq staff notified Curanex that it regained compliance
Key Terms
reverse stock split, Nasdaq Listing Rule 5550(a)(2), Listing Qualifications Department, minimum bid price
4 terms
reverse stock split financial
"On August 20, 2026, the Company effected a 1-for-20 reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Nasdaq Listing Rule 5550(a)(2) regulatory
"failed to maintain a minimum bid price of $1.00 ... as required by Nasdaq Listing Rule 5550(a)(2)"
Listing Qualifications Department regulatory
"the Company was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC"
A listing qualifications department is the part of a stock exchange that checks whether a company meets the exchange’s rules for being listed and staying listed. Think of it as a gatekeeper or building inspector: it reviews financial statements, disclosure practices and corporate governance, flags problems and can require fixes or remove a company’s shares. Investors care because its decisions affect whether a stock remains tradable and how much trust to place in a company’s reporting.
minimum bid price financial
"failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days"
The minimum bid price is the lowest share price that a market, regulator, or specific offering will accept for a trade, listing, or auction—think of it as a reserve or floor that a stock must meet to qualify for certain actions. It matters to investors because falling below that floor can limit trading options, trigger compliance measures or delisting risks, and affect liquidity and the perceived value of a holding, much like a reserve price in an auction sets the baseline for a sale.
FAQ
What Nasdaq compliance update did CURX announce on September 3, 2026?
Curanex announced that Nasdaq staff determined the company has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its stock maintained a closing bid price of at least $1.00 for 10 consecutive business days ending September 2, 2026.
Why did CURX conduct a 1-for-20 reverse stock split?
Curanex conducted a 1-for-20 reverse stock split of its outstanding common stock on August 20, 2026 specifically to help regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum $1.00 bid price for continued trading on The Nasdaq Capital Market.
When did CURX first receive a Nasdaq minimum bid-price deficiency notice?
Curanex received a deficiency notice from Nasdaq’s Listing Qualifications Department on November 5, 2025, stating that its common stock had failed to maintain a minimum $1.00 bid price for 30 consecutive business days as required for continued listing.
Over what period did CURX’s stock meet Nasdaq’s $1.00 minimum bid requirement?
Nasdaq staff determined that from August 20, 2026 through September 2, 2026, Curanex’s common stock had a closing bid price of $1.00 or greater for 10 consecutive business days, satisfying the minimum bid requirement.
Is the Nasdaq bid-price compliance matter for CURX now resolved?
Yes. Nasdaq staff notified Curanex on September 3, 2026 that it has regained compliance with Listing Rule 5550(a)(2), and the company states that this minimum bid-price matter is now closed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
